These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20101337)

  • 1. Efficacy and tolerability of cefditoren pivoxil in uncomplicated skin and skin structure infections in Indian patients.
    Manaktala C; Singh AK; Verma M; Sachdeva A; Sharma H; Roy A; Jalali RK; Gowrishankar R; Kumar A; Kumar AS; Jayaraman AM; Swarnkar B; Srinivas CR; Nayak C; Duttaroy D; Umrigar D; Jesudanam M; Maheshwari N; Shetty P; Singh RP; Ghate S; Sacchidanand S; Tolat S; Bhoira S; Marfatia Y
    Indian J Dermatol; 2009; 54(4):350-6. PubMed ID: 20101337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
    Bucko AD; Hunt BJ; Kidd SL; Hom R
    Clin Ther; 2002 Jul; 24(7):1134-47. PubMed ID: 12182257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
    Sadahira T; Wada K; Araki M; Ishii A; Takamoto A; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y; Kumon H;
    J Antimicrob Chemother; 2017 Feb; 72(2):529-534. PubMed ID: 27733519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefditoren pivoxil.
    Darkes MJ; Plosker GL
    Drugs; 2002; 62(2):319-36; discussion 337-8. PubMed ID: 11817976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
    Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
    Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on cefditoren pivoxil in bacterial infections.
    Wellington K; Curran MP
    Treat Respir Med; 2005; 4(2):149-52. PubMed ID: 15813670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study.
    Poachanukoon O; Tangsathapornpong A; Tanuchit S
    Clin Exp Otorhinolaryngol; 2015 Jun; 8(2):129-35. PubMed ID: 26045911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-day oral cefditoren pivoxil versus 10-day oral amoxicillin for pediatric group A streptococcal pharyngotonsillitis.
    Ozaki T; Nishimura N; Suzuki M; Narita A; Watanabe N; Ahn J; Koyama N; Ushida H; Nakane K; Yasuda N; Funahashi K
    J Infect Chemother; 2008 Jun; 14(3):213-8. PubMed ID: 18574657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections.
    Wellington K; Curran MP
    Drugs; 2004; 64(22):2597-618. PubMed ID: 15516158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
    Poachanukoon O; Kitcharoensakkul M
    Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
    van Zyl L; le Roux JG; LaFata JA; Volk RS; Palo WA; Flamm R; Hom RC
    Clin Ther; 2002 Nov; 24(11):1840-53. PubMed ID: 12501878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
    Alvarez-Sala JL; Kardos P; Martínez-Beltrán J; Coronel P; Aguilar L
    Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of cefditoren pivoxil in treatment of respiratory infections, a clinical study].
    Li JT; Gao L; Xue F; Hao FL; Wang Q; Cai BQ; Gan CL; Liu YN; Yu BX; He LX; Hu BJ; Chen XH; Zheng JC; Yu YS; Lu FF; Liang DR; Cai YN; Kang J; Kong LF; Xiao ZL; Zheng JP; Liu J; Yang WX; Zhou J
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):391-4. PubMed ID: 12820915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.
    Miyazaki T; Fukushima K; Hashiguchi K; Inoue Y; Mihara T; Sawai T; Suyama N; Kobayashi T; Kondo A; Fukuda Y; Harada Y; Sasaki E; Kaku N; Ide S; Takazono T; Saijo T; Kosai K; Morinaga Y; Nakamura S; Yamamoto K; Imamura Y; Izumikawa K; Yanagihara K; Kohno S; Mukae H
    J Infect Chemother; 2019 Sep; 25(9):702-707. PubMed ID: 30982729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication.
    Blasi F; Tarsia P; Mantero M; Morlacchi LC; Piffer F
    Ther Clin Risk Manag; 2013; 9():55-64. PubMed ID: 23430960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Trial to Reconfirm the Efficacy and Safety of Cefetamet Pivoxil Treatment in Sinusitis Patients: A Double-Blind, Randomized, Parallel Designed, Multicenter, Active Comparator Study (CASIS Study).
    Park CS; Cho JH; Lee HM; Kim KS; Kim JK; Kim DY; Baek BJ; Kim HJ; Kim YD; Hwang CS; Kim ST; Cho SH; Kim YM; Lee SH; Jeong JH; In SM; Kim BG
    Ear Nose Throat J; 2023 Feb; 102(2):101-109. PubMed ID: 34427151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
    Sádaba B; Azanza JR; Quetglas EG; Campanero MA; Honorato J; Coronel P; Gimeno M
    Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
    Tack KJ; Littlejohn TW; Mailloux G; Wolf MM; Keyserling CH
    Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.